Showing results (1891-1900 of 2,159) with videos related to

Sort By:
Pageof 216
Cancer Prevention Research (Philadelphia, Pa.)|June 18, 2021
Breast-Specific Molecular Clocks Comprised of ELF5 Expression and Promoter Methylation Identify Individuals Susceptible to Cancer InitiationMasaru Miyano, Rosalyn W Sayaman, Sundus F Shalabi, et al.
Cancer Gene Therapy|April 15, 2024
Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progressionKentaro Watanabe, Keiji Tasaka, Hideto Ogata, et al.
Pigment Cell & Melanoma Research|November 26, 2025
Updated Analysis of Albinism in Japan: 290 Families With Novel Pathological VariantsKen Okamura, Toru Saito, Naoki Oiso, et al.
Lung Cancer (Amsterdam, Netherlands)|October 19, 2015
The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in KoreaHee Joung Kim, Seung Hun Jang, Jeong-Seon Ryu, et al.
Pediatric Surgery International|September 29, 2022
Quality of life after type-A esophageal atresia surgery: changes over time and effect of pre-anastomotic elongationGo Miyano, Toshiaki Takahashi, Susumu Yamada, et al.
Oncotarget|August 25, 2016
Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrenceMasami Ueda, Tomohiro Iguchi, Takaaki Masuda, et al.
Molecular Pain|October 24, 2017
Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive toleranceTomohisa Mori, Naoko Kuzumaki, Takamichi Arima, et al.
Pediatric Blood & Cancer|September 30, 2017
Genetic heterogeneity of uncharacterized childhood autoimmune diseases with lymphoproliferationMasatoshi Takagi, Akihiro Hoshino, Kenichi Yoshida, et al.
Nature Communications|September 9, 2018
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasiaYusuke Shiozawa, Luca Malcovati, Anna Gallì, et al.
Scientific Reports|August 14, 2015
Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugsAsuka Nakata, Ryo Yoshida, Rui Yamaguchi, et al.
Pageof 216